loader2
Partner With Us NRI
Zensar Technologies Ltd>
  • CMP : 578.7 Chg : -2.40 (-0.41%)
  • Target : 365.0 (19.67%)
  • Target Period : 12-18 Month

13 May 2022

Highest ever client addition…

About The Stock

Zensar Technologies (Zensar) offers application & IMS services to hi-tech, manufacturing, retail and BFSI.

  • Zensar has grown organically and inorganically over the years
  • Net debt free and healthy double digit return ratio (with RoCE of 19%)
Q4FY22

Zensar reported weak numbers on the margin front.

  • Revenue grew 4.2% in CC terms while dollar revenue grew 4.1% QoQ
  • EBITDA margins declined 20 bps QoQ to 14.2%
  • Digital services contribute 72% of revenues
What should Investors do?

Zensar’s share price has grown by ~1.76x over the past five years (from ~₹ 166.9 in May 2017 to ~₹ 305 levels in May 2022).

  • We continue to remain positive and retain our BUY rating on the stock.
Target Price Valuation

We value Zensar at ₹ 365 i.e. 16x P/E on FY24E

Key Triggers for future price performance
  • Zensar is addressing key shortages of the past. The new CEO has devised a strategy to focus on experience side and build capabilities in digital engineering, data, artificial intelligence and machine learning
  • Driving deal momentum, annuity revenues, increasing investment in sales & talent, leadership and tuck in acquisition to build capability bodes well for long term revenue growth
  • Expect dollar revenue CAGR of 13.5% over FY22-24E
Alternate Stock Ideas

Apart from Zensar, in our IT coverage we also like Persistent.

  • Key beneficiary of growth in digital technologies and exposure to growth segments like healthcare & BFSI
  • BUY with a target price of ₹ 5,075

Key Financial Summary

Particulars FY19 FY20 FY21 FY22 5 Year CAGR(FY17-FY22) FY23E FY24E 2 Year CAGR (FY22-FY24E)
Net Sales 3,982.5 4,181.7 3,781.4 4,243.8 6.8 4,976.6 5,573.7 14.6
EBITDA 492.8 507.1 684.8 656.5 11.2 771.4 891.8 16.6
EBITDA Margin (%) 12.4 12.1 18.1 15.5 - 15.5 16.0 -
Reported PAT 313.6 263.4 300.0 416.1 12.1 423.7 521.4 11.9
EPS (|) 13.9 11.5 13.2 18.3 - 18.6 22.9 -
P/E 21.9 26.5 23.1 16.7 - 16.4 13.3 -
ROE (%) 16.1 12.6 12.8 15.5 - 14.1 15.4 -
ROCE (%) 17.6 12.5 18.9 15.5 - 17.5 18.9 -
Source: Company, ICICI Direct Research

Key takeaways of recent quarter & conference call highlights

  • The company reported revenue of US$153.2 mn, 4.1% QoQ dollar growth while CC growth was 4.2% QoQ. In rupee terms, revenue grew 4.7% QoQ to | 1154 crore. The company reported 15.3% growth in FY22 to US$569.4 mn. The company did not call out organic growth but M3bi has a US$7.5 mn quarterly run rate. Hence, our calculation suggests organic growth of ~10% in FY22
  • Geography wise, growth came in from US markets as it grew 3.4% QoQ, while Europe grew 9.9% QoQ and Africa region reported a flattish growth of 0.4% QoQ
  • Vertical wise Hi-Tech & Engineering, which contributes 45.9% of revenues, grew 3% QoQ. Other verticals such as retail, BFSI & Emerging, grew 4.1%, 5.1% and 5.9% QoQ, respectively
  • EBITDA margins for the quarter declined 20 bps QoQ to 14.2%; due to increase in employee cost & other expenses. The company guiding for mid teen EBITDA margin for FY23, taking into consideration of wage hikes which would take place in Q2FY23. The company called out following levers on account of which it is guiding for high teen EBITDA margin in the medium term
  • Margin expansion levers are: i) elevated fresher hiring in FY23, the company mentioned that they are increasing catchment area for fresher hiring as they are going into tier II and tier III cities ii) Continued focus on offshoring, 57% of revenue mix for FY22 iii) Opening of delivery centres, both in India as well as near shore locations. They recently opened delivery centre in Kolkata in India as well Columbia and in some near shore locations in Europe. Iv) pricing – the company has been getting price hikes in the new order wins especially on the digital side. V) operational efficiency
  • The company indicated that the demand environment continued to be healthy and they are seeing strong growth for the foreseeable future. Zensar indicated that they are seeing more mid and small size deals in the market while the share of large size deal has been shrinking
  • The company maintained that traditionally they were having stronghold in banking but it has invested substantially in the last couple of years in insurance vertical to scale it up
  • The company indicated that in FY22, they have aligned key leaderships in few geographies and verticals and the process will continue in FY23. The company also appointed Sachin Zute as the new CFO. Prior to joining Zensar he served as Vice President – Finance and Head of Business Finance Industry segments, Mergers & Acquisitions and Treasury with Infosys Ltd
  • The company indicated that deal wins for the quarter were strong at US$165.6 mn, up 32.3% QoQ. Deal wins for FY22 were at US$575 mn. The company indicated that renewal vs new deal ration is at 60:40. Zensar indicated that client mix has been changing wherein concentration of top 10 has come down while there has been increase in top 20 clients. Hence, the growth is expected to be broad based, going forward. The company also indicated that incremental deals would be a good mix of repeatable and discretionary business
  • The company indicated that there could be some headwinds on account of current macroeconomic challenges but they are confident of strong growth in FY23 as they aspire to be in top quartile in the space
  • It added 43 new clients in FY22, its highest ever addition
 
Variance Analysis
 
   Q4FY22   Q4FY21   YoY (%)   Q3FY22   QoQ (%)  Comments
Revenue 1,153.8 876.7 31.6 1,102.5 4.7 revenue growth aided by Europe region, which reported growth of 9.9% QoQ
Employee expense 806 571 41.1 776 3.8  
             
Gross Margin 348 306 13.9 327 6.6  
Gross margin (%) 30.2 34.9 -471 bps 29.6 55 bps  
other expense 184 132 39.9 168 9.4  
             
EBITDA 164 174 -5.8 158 3.7  
EBITDA Margin (%) 14.2 19.9 -565 bps 14.4 -14 bps EBITDA margin decline due to sharp rise in other expenses
Depreciation & amortisation 48 45 8.1 47 1.5  
EBIT 116 130 -10.6 111 4.6  
EBIT Margin (%) 10.1 14.8 -474 bps 10.1 -1 bps  
Other income (less interest) 63 -6 -1,232.1 15 317.1  
PBT 180 124 44.5 126 42.2  
Tax paid 49 31 55.7 34 44.2  
PAT 131 93 40.7 92 41.5  

Terms & conditions and other disclosures

ANALYST CERTIFICATION

I/We, Sameer Pardikar, MBA, Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. It is also confirmed that above mentioned Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months and do not serve as an officer, director or employee of the companies mentioned in the report.

Terms & conditions and other disclosures:

ICICI Securities Limited (ICICI Securities) is a full-service, integrated investment banking and is, inter alia, engaged in the business of stock brokering and distribution of financial products.

ICICI Securities is Sebi registered stock broker, merchant banker, investment adviser, portfolio manager and Research Analyst. ICICI Securities is registered with Insurance Regulatory Development Authority of India Limited (IRDAI) as a composite corporate agent and with PFRDA as a Point of Presence. ICICI Securities Limited Research Analyst SEBI Registration Number – INH000000990. ICICI Securities Limited SEBI Registration is INZ000183631 for stock broker. ICICI Securities is a subsidiary of ICICI Bank which is India’s largest private sector bank and has its various subsidiaries engaged in businesses of housing finance, asset management, life insurance, general insurance, venture capital fund management, etc. (“associates”), the details in respect of which are available on www.icicibank.com. 

ICICI Securities is one of the leading merchant bankers/ underwriters of securities and participate in virtually all securities trading markets in India. We and our associates might have investment banking and other business relationship with a significant percentage of companies covered by our Investment Research Department. ICICI Securities and its analysts, persons reporting to analysts and their relatives are generally prohibited from maintaining a financial interest in the securities or derivatives of any companies that the analysts cover. 

Recommendation in reports based on technical and derivative analysis centre on studying charts of a stocks price movement, outstanding positions, trading volume etc as opposed to focusing on a companys fundamentals and, as such, may not match with the recommendation in fundamental reports. Investors may visit icicidirect.com to view the Fundamental and Technical Research Reports. 

Our proprietary trading and investment businesses may make investment decisions that are inconsistent with the recommendations expressed herein. 

ICICI Securities Limited has two independent equity research groups: Institutional Research and Retail Research. This report has been prepared by the Retail Research. The views and opinions expressed in this document may or may not match or may be contrary with the views, estimates, rating, and target price of the Institutional Research. 

The information and opinions in this report have been prepared by ICICI Securities and are subject to change without any notice. The report and information contained herein is strictly confidential and meant solely for the selected recipient and may not be altered in any way, transmitted to, copied or distributed, in part or in whole, to any other person or to the media or reproduced in any form, without prior written consent of ICICI Securities. While we would endeavour to update the information herein on a reasonable basis, ICICI Securities is under no obligation to update or keep the information current. Also, there may be regulatory, compliance or other reasons that may prevent ICICI Securities from doing so. Non-rated securities indicate that rating on a particular security has been suspended temporarily and such suspension is in compliance with applicable regulations and/or ICICI Securities policies, in circumstances where ICICI Securities might be acting in an advisory capacity to this company, or in certain other circumstances. 

This report is based on information obtained from public sources and sources believed to be reliable, but no independent verification has been made nor is its accuracy or completeness guaranteed. This report and information herein is solely for informational purpose and shall not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. ICICI Securities will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances. The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient. This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks. The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason. ICICI Securities accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see Risk Disclosure Document to understand the risks associated before investing in the securities markets. Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. 

ICICI Securities or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. 

ICICI Securities or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction. 

ICICI Securities or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the companies mentioned in the report in the past twelve months. 

ICICI Securities encourages independence in research report preparation and strives to minimize conflict in preparation of research report. ICICI Securities or its associates or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither ICICI Securities nor Research Analysts and their relatives have any material conflict of interest at the time of publication of this report. 

Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. 

ICICI Securities or its subsidiaries collectively or Research Analysts or their relatives do not own 1% or more of the equity securities of the Company mentioned in the report as of the last day of the month preceding the publication of the research report. 

RATING RATIONALE

ICICI Direct endeavours to provide objective opinions and recommendations. ICICI Direct assigns ratings to its stocks according -to their notional target price vs. current market price and then categorizes them as Buy, Hold, Reduce and Sell. The performance horizon is two years unless specified and the notional target price is defined as the analysts valuation for a stock

Buy: >15%

Hold: -5%to 15%;

Reduce: -15% to -5%;

Sell: <-15% 

Pankaj Pandey

Head – Research

pankaj.pandey@icicisecurities.com

 

 

ICICI Direct Research Desk,

ICICI Securities Limited,

1st Floor, Akruti Trade Centre,

Road No 7, MIDC,

Andheri (East)

Mumbai – 400 093

 

 

research@icicidirect.com

Read More